evofloxacin in Hematopoetic stem cell transplant

Phase 3

Recruiting

• Conditions: antibiotic prophylaxis in hematopoetic stem cell transplantation.; Complications of bone marrow transplant; T86.0

• Registration Number: IRCT20100127003210N17
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Candidate for Allogeneic Stem Cell Transplantation
Age over 18

Exclusion Criteria

Chronic renal failure
Age over 65
Pregnancy
Unwillingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fever detection. Timepoint: every 6 hours till engraftment. Method of measurement: Via mercury thermometer.;Infection. Timepoint: Daily till engraftment happen. Method of measurement: 1. Clinical sign and symptoms. 2.Laboratory data.

Secondary Outcome Measures

Name	Time	Method
Duration of neutropenic status. Timepoint: Daily. Method of measurement: Blood Neutrophile count.;Hospital length of stay. Timepoint: Daily. Method of measurement: recording number of hospitalized days.;Need for other antibiotic consuption. Timepoint: Daily. Method of measurement: Patient's medication list.;Engraftment time. Timepoint: Daily. Method of measurement: Blood cells count.